Hyderabad: Hospitalization due to severe infection and mortality among individuals who received Covid vaccines are much less, a demographic analysis of the breakthrough Covid-19 infections taken up by the Indian Medical Research Council (ICMR) said. The analysis of breakthrough cases is a clear indication that vaccines are the best way to reduce severity and mortality. Covid-19 patients.
There will be occasions where persons who are fully vaccinated may be exposed to the infection, and such cases are called breakthrough cases. The ICMR study, which analyzed 677 such breakthrough infections from across the country between March and June, indicated that only 9.9% of the breakthrough cases (67 patients) required hospitalization and the mortality rate was only 0.4%.
The demographic analysis conducted in 19 states also indicated that the Delta variant played a major role in the breakthrough cases. Of the 677 breakthrough cases analyzed, 99.6% recovered patients, that is 674 individuals, while the mortality rate was approximately 0.4%, ie three individuals died.
Among individuals who received both doses Covid vaccination, the hospitalization was 8.9%, while for those who received one dose of the vaccine, it was 16.5%. Of the 677 breakthrough cases, 604 individuals received Covishield, 71 received Covaxin, and two received the Sinopharm vaccine developed in China.
The ICMR analysis also indicated that 482 breakthrough cases had symptoms while 195 individuals had no symptoms during the infection. About 47.6% of the persons who received both the doses and 36.5% who received one dose Covid the study said the vaccine had contact with the laboratory-confirmed SARS-CoV-2 case.
The demographic analysis of breakthrough cases was carried out in Arunachal Pradesh, Assam, Chandigarh, Delhi, Gujarat, Haryana, Jammu and Kashmir, Jharkhand, Karnataka, Kerala, Madhya Pradesh, Maharashtra, Manipur, Tamil Nadu, Uttarakhand, West Bengal, Punjab, West Bengal, Punjab and Rajasthan.
Source: Telangana Today